Standard therapies: solutions for improving therapeutic effects of immune checkpoint inhibitors on colorectal cancer

Immunotherapy using immune checkpoint inhibitors has opened a new era for cancer management. In colorectal cancer, patients with a phenotype of deficient mismatch repair or high microsatellite instability benefit from immunotherapy. However, the response of rest cases to immunotherapy alone is still...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Tingting, Tong, Weihua, Ma, Siyang, Chang, Pengyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466849/
https://www.ncbi.nlm.nih.gov/pubmed/32934878
http://dx.doi.org/10.1080/2162402X.2020.1773205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466849/
https://www.ncbi.nlm.nih.gov/pubmed/32934878
http://dx.doi.org/10.1080/2162402X.2020.1773205

Ejemplares similares